Combined liver surgery and RFA for patients with gastroenteropancreatic endocrine tumors presenting with more than 15 metastases to the liver

European Journal of Surgical Oncology

Volumn 35, Issue 10, 2009, Pages 1092-1097

  Elias, D ^a,b   Goere D ^a,b   Leroux, G ^a,b   Dromain, C ^a,b   Leboulleux, S ^a,b   de Baere, Th ^a,b   Ducreux, M ^a,b   Baudin, E ^a,b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Endocrine tumor; Hepatectomy; Liver metastases; Radiofrequency ablation

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; FEASIBILITY STUDY; FEMALE; GASTROENTEROPANCREATIC ENDOCRINE CARCINOMA; GASTROINTESTINAL CARCINOMA; HUMAN; LIVER METASTASIS; LIVER RESECTION; LIVER SURGERY; MALE; MORBIDITY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SURVIVAL RATE;

ADULT; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; GASTROINTESTINAL NEOPLASMS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 69949110585     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.02.017     Document Type: Article

References (26)

1. Baudin E. Gastroenteropancreatic endocrine tumors: clinical characterization before therapy. A review. Nat Clin Pract 3 (2007) 228-239
2. Que F.G., Nagorney D.M., Batts K.P., Linz, and Kools L.K. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 169 (1995) 36-42
3. Chen H., Hardacre J.M., Uzar A., Cameron J.L., and Choti M.A. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg 187 (1998) 88-93
4. Chamberlain R.S., Canes D., Brown T.K., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes. J Am Coll Surg 190 (2000) 432-445
5. Yao K.A., Talamonti M.S., Nemcek A., et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 130 (2001) 677-685
6. Sarmiento J.M., Heywood G., Rubin J., Ilstrup D.M., Nagorney D., and Que F.G. Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival. J Am Coll Surg 197 (2003) 29-37
7. Elias D., Lasser P., Ducreux M., et al. Liver resection (and associated extra-hepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study. Surgery 133 (2003) 375-382
8. Malka D., Durante C., Dromain C., et al. Prognostic factors of metastatic well-differentiated gastroenteropancreatic endocrine tumors. Gastroenterol Clin Biol 31 (2007) A107
9. Dromain C., de Baere T., Baudin E., et al. MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques. AJR 180 (2003) 121-128
10. Mazzaglia P.J., Berber E., Milas M., and Siperstein A.E. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142 (2007) 10-19
11. Roche A., Soyer P., Elias D., Breitmayer F., Gad M., and Rougier P. Pre-operative portal vein embolisation for hepatic metastases. J Intervent Radiol 6 (1991) 63-66
12. Elias D., Ouellet J.F., De Baere T., Lasser P., and Roche A. Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival. Surgery 131 (2002) 294-299
13. Elias D., Lasser P., Debaene B., et al. Intermittent exclusion of the liver without vena cava clamping during major hepatectomy. Br J Surg 82 (1995) 1535-1539
14. Elias D., Debaere T., Muttillo I., Cavalcanti A., Coyle C., and Roche A. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol 67 (1998) 190-191
15. Elias D., El Otmany A., Goharin A., Attalah D., and de Baere T. Intraductal cooling of the main bile ducts during intraoperative radiofrequency ablation. J Surg Oncol 76 (2001) 297-300
16. Elias D., Pocard M., Sideris L., Dromain C., and De Baere T. Intraductal cooling of the main hepatic ducts during radiofrequency ablation prevents biliary stenosis. J Am Coll Surg 198 (2004) 717-721
17. Ouellet J.F., Pessaux P., Pocard M., and Elias D. Transmetastasis curative liver resection immediately following radiofrequency destruction. J Surg Oncol 81 (2002) 108-110
18. Elias D., Manganas D., Benizri E., et al. The trans-metastasis hepatectomy (through metastases previously ablated with radiofrequency): results of a 13-case study of colorectal cancer. J Surg Oncol 93 (2006) 8-12
19. Nordic NE. Tumour Group. Guidelines for management of gastropancreatic neuroendocrine tumours. Acta Oncol 43 (2004) 617-625
20. Weidenmann B., Jensen R.T., Mignon M., et al. Consensus conference. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors. World J Surg 22 (1998) 309-318
21. Cadiot G., Baudin E., Partensky C., and Runievski P. French guidelines for digestive cancers. Digestive endocrine tumors. Gastroenterol Clin Biol 30 (2006) 2S91-7
22. Modlin I.M., and Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 79 (1997) 813-829
23. Adam E., Laurent A., Azoulay D., Castaing D., and Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232 (2000) 777-785
24. Jaeck D., Bachelier P., Nakano H., et al. One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185 (2003) 221-229
25. Ota T., Araida T., Yamamoto M., and Takasaki K. Operative outcome and problems of right hepatic lobectomy with pancreatoduodenectomy for advanced carcinoma of the biliary tract. J Hepatobiliary Pancreat Surg 2 (2007) 155-158
26. Ebata T., Nagino M., Nishio H., Arai T., and Nimura Y. Right hepatopancreatoduodenectomy: improvements over 23 years to attain acceptability. J Hepatobiliary Pancreat Surg 2 (2007) 131-135